Showing 9,281 - 9,300 results of 226,405 for search '(( a ((((greater decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 1.79s Refine Results
  1. 9281

    The effect of decreasing recombinase expression on circuit performance. by Jack E. Bowyer (9874262)

    Published 2020
    “…The model predictions align qualitatively with our data, demonstrating a decline in circuit performance as recombinase expression decreases.…”
  2. 9282

    The locomotor activity decreased in the first extinction session. by Jian-Jun Zhang (334146)

    Published 2017
    “…<p>(a) Compared with the last acquisition, the locomotor activity decreased in the first extinction day (n = 47). …”
  3. 9283
  4. 9284
  5. 9285
  6. 9286
  7. 9287
  8. 9288
  9. 9289
  10. 9290
  11. 9291

    GA decreases CD11c expression. by Refik Pul (292867)

    Published 2013
    “…<p><b>A.</b> Significant decrease in CD11c expression after 24 h of GA treatment. …”
  12. 9292
  13. 9293
  14. 9294
  15. 9295
  16. 9296

    Image 3_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tif by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  17. 9297

    Image 6_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  18. 9298

    Image 7_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  19. 9299

    Image 5_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”
  20. 9300

    Image 9_The CYP4/20-HETE/GRP75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.tiff by James P. Hardwick (20634155)

    Published 2025
    “…Increased synthesis of 20-HETE correlated with the expression of CYP4A11 genes but not CYP4F2. These results were confirmed by increased P4504A11 protein levels and decreased P4504F2 protein levels during the development and progression of MASLD. …”